Image

Canada Meetings on Computer Aided Drug Designing and Drug Delivery (CSE)

Date & Time

Mon, Sep 28 08:00 AM 2020 - Tue, Sep 29 08:00 AM 2020
Add to calendar

Venue

, Toronto, , Canada,
View in map

Friends who are going

Connect to Facebook

Share

Price
$1,099.00-$1,899.00


Description

Canada Meetings on Computer Aided Drug Designing and Drug Delivery

About


Overview

Canada Meetings on Computer Aided Drug Designing and Drug Delivery 2019

CADD and Drug Delivery 2019 is once again pleased to support scientific research in the field of drug development and drug delivery.

The “Canada Meetings on Computer Aided Drug Designing and Drug Delivery” brings together leading drug development and drug delivery scientists from both industry and academia to share and discuss their latest work.

We feel proud to present the highly anticipated Canada Meetings on Computer Aided Drug Designing and Drug Delivery to be held on 27-28 September 2019, Toronto, Canada.

The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions. This event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

The program agenda is stuffed with selected talks on topics related to drug development and drug delivery.

Key benefits of attending:

Learn about the latest drug delivery technology solutions for both small and large molecule drugs.
Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and explore areas for potential collaboration.
Discover the current drug delivery needs of pharma and biotech companies and determine what they are looking for in terms of external delivery technologies.
Understand the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.

Submit us your abstract here @ Abstract Submission.

Key Sessions/Tracks

Track 1: Computer Aided Drug Designing

Ligand and structure based drug design
Computational Chemistry
Molecular modelling
Enzyme as target
Receptor as target
QSAR/QSPR Quantitative structure activity/property relationships

Track 2 : Advances in Drug Delivery

Novel Drug Delivery Systems
Routes of Drug Administration
Delivery of new therapeutic modalities
Delivery of emerging biologics including mRNA, siRNA delivery, DNA delivery
Vaccine Based Drug Delivery Technology

Track 3 : Drug Delivery Devices

Needle-free delivery systems
Patient centered integrated device implementation
Devices development - continuous administration of drugs
Human Factors, Behavioural Design And Human Centred Design For Delivery Device Development

Track 4 : Advancements in Drug Designing

GPCR-Targeted Drug Design
Lead Optimization for Drug Metabolism and Safety

Track 5: Novel Drug Discovery and Drug Delivery

Role of computational biology
Pioneering digital health and smart drug delivery systems
Ligand binding studies
Phage display technology for clinical application of protein drugs

Track 6: Large Molecule Drug Formulation

Protein-Protein Interactions
Inflammation and Autoimmune Inhibitors
Kinase Inhibitor Chemistry
Vaccines, Antibodies, Biotherapeutics
Formulation development for biosimilars

Track 7: Bioanalysis and Stabilisation

Bioanalytical development for large molecules
Analytical development for novel therapeutics
Analytical strategies for novel proteins and antibodies
Stability testing and stability approaches for biologics
Understanding the characterisation of large molecules
Novel analytical tools to analyse particles

Track 8: ADME

ADME (adsorption, distribution, metabolism and excretion)Of drugs
Metabolism and toxicology
Antiviral and antimicrobial activity
Drug receptor interaction
Kojic acid as a tyrosine inhibitor

Track 9: Medicinal Chemistry and Drug Discovery

Target discovery and validation
Molecular modelling
Drug receptor interactions
Pro drug synthesis and drug targeting
Toxicity, and therapeutic applications of antibiotics, antifungals, and antivirals

Track 10: Nanotechnology in Drug Delivery

Nanoparticles that deliver three anti-cancer drugs to the lymph nodes
Sustained drug delivery using a hydrogen
Photosensitizing agent to enhance the ability of drug carrying nanoparticles
Nanotechnology in Drug Delivery - Heart Disease
Carbon nanofibers penetrate diseased cells
Nanotechnology in Drug Delivery - Aging and other areas

Track 11: Chem Virology

Rapid Transmission
ZIKV-Processing on the microfluidic cassette
ZIKA virus infection may prevent reinfection
Zika infection-A global threat to human population
Major possible symptoms
Drugs and vaccines available so far

Track 12: Posology

Factors affecting the drug dosage
Route of Administration

Track 13: Cancer Studies: Drug Delivery Chemistry

Magnetoelectric nanoparticles
Nanoparticle drug delivery
Problems of multidrug resistance in cancer therapies
Taxoids as potent cytotoxic agents for tumour targeting drug delivery

Track 14: Drug Biotransformation and Disposition

High resolution-mass spectrometry (HR-MS) technology
Data-mining tools
AB SCIEX TripleTOF™ 5600 System for the study of drug metabolism in BDC rats and CYP inhibition cocktail assays.

Track 15: Small Molecule Drug Formulation

Recent progress in amorphous solid dispersions
Advanced formulation strategies & methods for small molecules
Overcoming key formulation challenges for small molecules
Nano-formulations
Quality-by-Design approaches
Excipients for small molecule formulation

Track 16: Drug Delivery Systems

Drug Delivery Technologies
Drug Delivery Innovation

AGENDA 2018

------------------------------
2019 Upcoming Soon
------------------------------

Day 1 September 24, 2018
Conference Hall: Superior Ballroom B
Registrations
08:30-08:55 Opening Ceremony

Keynote Forum
08:55-09:00 Introduction
09:00-09:30 Title: Amyloid hypothesis and drug development for Alzheimer’s disorder: A critical review
Oleg V Tcheremissine, Atrium Health, USA
09:30-10:00 Title: Multivalent polymer conjugate inhibits aggregation of ß amyloid and
disassembles amyloid fibrils – potential for a polymer therapeutic
Edwin G Moore, University of Illinois, Urbana
10:00-10:30 Title: Development and commercialization of oral peptide and protein therapeutics:
Trends and perspectives
Panayiotis P Constantinides, Biopharmaceutical & Drug Delivery Consulting LLC, USA
Group Photo & Panel Discussion 10:30-10:40
Networking and Refreshment Break 10:40-11:00 @ Foyer
11:00-11:30 Title: Solutions for collaborative drug discovery – Connecting researchers globally
Luke S Fisher, Collaborative Drug Discovery, Inc., USA
11:30-12:00 Title: Activating endocytosis for enhancing cellular delivery and modifying intracellular
targeting of therapeutics
Arwyn T Jones, Cardiff University, UK
12:00-12:30 Title: Pursuit of oral insulin is a reality: Is it simply a matter of when?
Prakash V Diwan, National Institute of Pharmaceutical Education and Research, India
12:30-13:00 Title: Minority populations in clinical trials
Rodney Villanueva & Oleg V Tcheremissine, Atrium Health, USA
Panel Discussion
Lunch Break 13:00-14:00 @ Michigan
Workshop
14:00-14:45 Title: Planning and submitting clinical trial applications to Ex US countries
Siddhartha Chowdhury, Northeastern University, USA
Sessions: Drug Discovery and Development | Patient-Centric Clinical Trials | Polymer–Peptide
Conjugates | Medicinal Chemistry and Drug Discovery | Drug Delivery Systems | Patient-Centric
Clinical Trials | Globalization of Clinical Trials
Session Chair: Edwin G Moore, University of Illinois, Urbana
Session Chair: Panayiotis P Constantinides, Biopharmaceutical & Drug Delivery Consulting LLC, USA
Session Introduction
14:45-15:05
Title: Implementing strategic financial management for clinical research
Brandon Furr, Atrium Health, USA
15:05-15:25
Title: Total syntheses and their biological evaluation of poison-frog alkaloids ent-cis195A
and cis-211A
Naoki Toyooka, University of Toyama, Japan
Panel Discussion
Networking and Refreshment Break 15:25-15:45 @ Foyer
15:45-16:05
Title: Magnetic nanoparticles: Application as RF hyperthermia therapy & contrast agent
in magnetic resonance imaging
Bijoy K Kuanr, Jawaharlal Nehru University, India
16:05-16:25 Title: The power of theory in developing the design of targeted nanoparticles
Ebtisam A Aldaais, Imam Abdulrahman Bin Faisal University, Saudi Arabia
16:25-16:45
Title: Designing of inhibitors for cancer phenotype: An experimental and computational
approach
Navaneetha Nambigari, Osmania University, India
16:45-17:05
Title: Development of small-molecule antagonists for PAC1 receptor aimed at drug
discovery of novel analgesics
Takuya Okada, University of Toyama, Japan
Panel Discussion
Networking & Business to Business Meeting 17:05-17:30

Day 2 September 25, 2018
Conference Hall: Superior Ballroom B

Keynote Forum
08:55-09:00 Introduction
09:00-09:30 Title: The dog story: A patient’s perspective on research and healthcare
Matt Cavallo, Patient Activation Network, USA
09:30-10:00 Title: SBDD of MDM2 and β-secretase inhibitors using FMO and machine learning
Tatsuya Takagi, Osaka University, Japan
10:00-10:30 Title: Modeling and simulation bring deep understandings of device drug delivery to
improve patient experience
Guiyong (Nick) Song, The University of Missouri, USA
Group Photo 10:30-10:40
Networking and Refreshment Break 10:40-11:00 @ Foyer
11:00-11:30 Title: Self administrative drug delivery devices made with plastics material – market
potential, customer discovery, challenges, manufacturing, and business model
Rahul R Panchal, Leonine Technologies Inc., USA
11:30-12:00 Title: Wonders and worries of nano technology in health care
Prakash V Diwan, Central Research Laboratory India
12:00-12:30 Title: Simple is better in nanomedicine
Vinod Labhasetwar, Lerner Research Institute, USA
Panel Discussion
Lunch Break 12:30-13:30 @ Michigan
Sessions: Clinical Research & Clinical Trials | Computer Aided Drug Designing | Drug Delivery
Systems| Nanotechnology in Drug Delivery | Clinical Trial Forecasting, Budgeting and Contracting|
Drug Discovery and Development| Patient-Centric Clinical Trials| Clinical Trial Site Selection and
Management| Pharmaceutical Nanotechnology |Drug Delivery Technology
Session Chair: Arwyn T Jones, Cardiff University, UK
Session Co-chair: Tatsuya Takagi, Osaka University, Japan
Session Introduction
13:30-13:50
Title: Metformin prevents high glucose induced disruption of coronary artery endothelial
barrier function and accelerates wound healing
Mohammad Tauseef, Chicago State University, USA
13:50-14:10 Title: Drug discovery research in academia
Rama Mishra, Northern Western University, USA
14:10-14:30
Title: Computer analysis of the heterogeneous surfaces using the unique fast multivariant
numerical procedure with the new clustering based models
Mirosław Kwiatkowski, AGH University of Science and Technology, Poland
14:30-14:50
Title: Ruthenium (II) polypyridyl complexes: Investigation of DNA binding study and
antiproliferative activity
Navaneetha Nambigari, Osmania University, India
Page 4
14:50-15:10
Title: Photodynamic mediated anticancer therapy using temoporfin (mthpc) loaded
liposomes
Sajid Ali, Philipps University Marburg, Germany
15:10-15:30 Title: Tribology in phantom pain in upper limb amputees
Sedegheh Malek Mohammadi, Orthotics and Prosthetics Research Clinic, Iran
Panel Discussion
Networking and Refreshment Break 15:30-15:50 @ Foyer
15:50-16:10
Title: Formulation and evaluation of mouth dissolving tablet of donepezil with super
disintegrants
Rubina Fatima, MRM Collage of Pharmacy, India
16:10-16:30
Title: A comparative study of crude extracts from some medicinal plants against malaria
pathogens with chloroquine drug
Ochieng O Anthony, Sumait University, Zanzibar
Poster Presentations 16:30-17:30
Poster 01
Title: Assessing the acceptability of N-of-1 trials/tests and their implementation: Getting
ready for piloting N-of-1 trials in ethiopia
Chalachew Alemayehu, University of Queensland, Australia
Poster 02 Title: Enhanced inner ear drug delivery assisted by ultrasound-aided microbubbles
Chih-Hung Wang, National Defense Medical Center, Taiwan
Poster 03
Title: Study start up for a global phase III study: A case study on a global multicenter
Phase III CNS studies
Siddhartha Chowdhury, Northeastern University, USA
Poster 04
Title: Overview of bioequivalence study methods with pharmacokinetics endpoint for
topical ophthalmic corticosteroid suspensions (ocs)
Yoriko Harigaya, University at Buffalo, USA
Poster 05 Title: Bioassay protocols: Semantic annotation to enable informatics
Luke S Fisher, Collaborative Drug Discovery, Inc., USA
Poster 06 Title: Innovative approaches for secure, modern collaborative drug discovery
Luke S Fisher, Collaborative Drug Discovery, Inc., USA
Poster 07
Title: A new perspective for possible formulation and characterization of BetaCyclodextrin/Poly(ethylene
glycol) crystalline inclusion complexes
Amal Abdulrahman, Clark Atlanta University, USA
Panel Discussion
Networking & Business to Business Meeting 17:30-17:45
Day 3 September 26, 2018
Conference Hall: Superior Ballroom B

Keynote Forum
09:30-10:00 Title: Biophysics of cell membrane lipids in cancer drug resistance: Drug transport and
drug delivery with nanoparticles
Vinod Labhasetwar, Lerner Research Institute, USA
Exhibitors Session 10:00-10:50
Panel Discussion
Networking and Refreshment Break 10:50-11:10 @ Foyer
Sessions: Clinical Trial Forecasting, Budgeting and Contracting | Novel Drug Delivery Systems| Drug
Delivery Technology | Pharmaceutical Nanotechnology
Session Chair: Prakash V Diwan, National Institute of Pharmaceutical Education and Research, India
Session Introduction
11:10-11:30 Title: Advance microneedles integrated transdermal patch for fast onset of Ivermectin
Rubina Fatima, MRM Collage of Pharmacy, India
11:30-11:50
Title: Lipid coated mesoporous silica nanoparticles for enhanced delivery and cellular
uptake of doxorubicin
Muhammad Umair Amin, Philipps University Marburg, Germany
Page 5
11:50-12:10
Title: A comparison of quality of prescriptions at primary, secondary and tertiary health
care facilities using prescription quality index tool
Jalpa V Suthara, Charotar University of Science and Technology, India
12:10-12:30 Title: Fair market value and grant plan: Tool for negotiating clinical trial site budgets
Siddhartha Chowdhury, Northeastern University, USA
12:30-12:50
Title: Endoscopy assisted laparoscopic resection of benign colonic polyps; a retrospective
study on safe approach to complete removal
Saad Ikram, Scunthorpe General Hospital, United Kingdom
Panel Discussions
Lunch Break- 12:50-13:50 @ Ontario
13:50-14:10
Title: Active metabolites of the marine strain Streptomyces sundarbansensis with highest
and selective antibacterial activity against MRSA
Mouloud Kecha, University of Bejaia, Algeria
14:10-14:30 Title:
Aala Ali Abdulrahim, University of Khartoum, Sudan
Video Presentation
14:30-14:50
Title: Transdermal Delivery of Pravastatin Loaded Microemulsion Based, Drug Delivery
System Developed By Central Composite Design
Anjali Devi Nippani, Kakatiya University, India
Panel Discussions
Networking & Business to Business Meeting 14:50-15:20 @ Foyer
Awards & Closing Cermony

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

VIO181109CRE

Reference:

https://www.eventbrite.com/e/canada-meetings-on-computer-aided-drug-designing-and-drug-delivery-cse-tickets-52406774072

Directions